Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metfo...

por Davies, Melanie, Heller, Simon, Sreenan, Seamus, Sapin, Hélène, Adetunji, Omolara, Tahbaz, Arash, Vora, Jiten
Publicado 2013

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future

por Kalra, Sanjay, Baruah, Manash P., Sahay, Rakesh K., Unnikrishnan, Ambika Gopalakrishnan, Uppal, Shweta, Adetunji, Omolara
Publicado 2016

A joint industry‐sponsored data monitoring committee model for observational, retrospective drug safety studies in the real‐world setting

por Major‐Pedersen, Atheline, McCullen, Mary Kate, Sabol, Mary Elizabeth, Adetunji, Omolara, Massaro, Joseph, Neugut, Alfred I., Sosa, Julie Ann, Hollenberg, Anthony N.
Publicado 2020